Years of lax regulations helped India build a booming market for clinical trials, but a recent move to strengthen patient protections has deflated demand and last year saw just 19 studies get underway in the country, according to The Pharma Letter.

…read more

Source: Indian clinical trials plummet 93% as local regs tighten up


0 No comments